Skip to content
Menu Close
Close button
Go back to News

Day One goes to the market for $150M as biotech kicks off NDA request for pediatric brain cancer drug

Day One Biopharmaceuticals will offer up more than 11.5 million shares to nab $150 million in gross proceeds after the biotech last month started a rolling submission for its pediatric brain cancer drug, which had a fresh data drop at last weekend’s ASCO.

Day One Biopharmaceuticals